Shenzhen Edge Medical Co., Ltd. (HKG:2675)
37.48
+0.76 (2.07%)
Jul 31, 2026, 4:08 PM HKT
Shenzhen Edge Medical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Shenzhen Edge Medical stock has a consensus rating of "Strong Buy" and an average price target of $74.81. The average 1-year stock price forecast is 99.60% higher than the current stock price, while the lowest is $56.16 (+49.84%) and the highest is $98.74 (+163.45%).
Price Target: $74.81 (+99.60%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Shenzhen Edge Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|
| Strong Buy | 0 | 1 | 2 |
| Buy | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Maintains $75.00 | Buy | Maintains | $75.00 | +100.11% | Jul 3, 2026 |
Unknown Analyst DBS No rating | DBS | Buy Initiates $68.10 | Buy | Initiates | $68.10 | +81.70% | Apr 30, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Initiates $81.00 | Buy | Initiates | $81.00 | +116.12% | Apr 22, 2026 |
Unknown Analyst GF Securities No rating | GF Securities | Buy Maintains $73.85 | Buy | Maintains | $73.85 | +97.04% | Apr 8, 2026 |
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $73.20 | Buy | Maintains | $73.20 | +95.30% | Feb 15, 2026 |
Financial Forecast
Revenue This Year
858.38M
from 455.72M
Increased by 88.36%
Revenue Next Year
1.35B
from 858.38M
Increased by 57.78%
EPS This Year
0.17
from -0.06
EPS Next Year
0.55
from 0.17
Increased by 222.90%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.